Hydrocortisone and Acetic Acid Otic Solution, USP

Manufacturer
Akorn Operating Company LLC
Effective date
2022-10-13
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-05-31 20:44:23

Label at a glance#

Producthydrocortisone and acetic acid
Active ingredientACETIC ACID, HYDROCORTISONE
Label structure11 sections

Indications and uses

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

Dosage and administration

Carefully remove all cerumen and debris to allow Hydrocortisone and Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Hydrocortisone and Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Hydrocortisone and ...

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Hydrocortisone and Acetic Acid Otic Solution, USP is a solution containing hydrocortisone (1%) and acetic acid (2%), in a propylene glycol vehicle containing benzethonium chloride (0.02%), citric acid (0.05%), propylene glycol diacetate (3%) and sodium acetate (0.015%). The empirical formulas for acetic acid and hydrocortisone are CH3COOH, and C21H30O5, with a molecular weight of 60.05 and 362.46, respectively. The structural formulas are:

Chemical structuracetic Acid
Chemical structuracetic Acid
Chemical Structure_Hydrocortisone
Chemical Structure_Hydrocortisone

Hydrocortisone and Acetic Acid is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Acetic acid is antibacterial and antifungal; hydrocortisone is antiinflammatory, antiallergic and antipruritic; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Hypersensitivity to Hydrocortisone and Acetic Acid or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

WARNINGS

WARNINGS SECTION

Discontinue promptly if sensitization or irritation occurs.

PRECAUTIONS

PRECAUTIONS SECTION

Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Carefully remove all cerumen and debris to allow Hydrocortisone and Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Hydrocortisone and Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Hydrocortisone and Acetic Acid every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Hydrocortisone and Acetic Acid 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

HOW SUPPLIED

HOW SUPPLIED SECTION

Hydrocortisone and Acetic Acid Otic Solution, USP, containing hydrocortisone (1%) and acetic acid (2%), is available in 10 mL, measured-drop, safety-tip plastic bottles (NDC 50383-901-10).

STORAGE

SPL UNCLASSIFIED SECTION

Store at room temperature, 20° to 25°C (68° to 77°F).

Keep container tightly closed.

Rx only

Distributed by:

Akorn Operating Company LLC

Gurnee, IL 60031

Rev. 901:04 07/22

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

carton
carton

AKORN

NDC 50383-901-10

Hydrocortisone and Acetic Acid Otic Solution, USP

10 mL

Rx only

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
313786acetic acid 2 % / hydrocortisone 1 % Otic SolutionPSN6
313786acetic acid 20 MG/ML / hydrocortisone 10 MG/ML Otic SolutionSCD6
313786acetic acid 2 % / hydrocortisone 1 % Otic SolutionSY6

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
HYDROCORTISONE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
15bd4439-874a-4934-9954-248e5455d460Product name120260310
9962b773-9f2e-22cc-0032-535e48ac417bProduct name320250724
56bb0587-1bf2-48b2-9d93-fc9f59d1eeb2Product name120250325
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
4d56e8eb-d741-d4a5-de3f-2bab1af75a60Product name720220608
626d7260-31b5-4412-84fd-579746adb6b3Product name120210513
8a011600-5e61-4c59-ab7b-54ab658a3b71Product name220181127
a919621a-248d-3c7a-1084-9f9ce286fdfdProduct name220181009
e7d5a174-836b-a0af-b014-cb0826c69ddcProduct name220181004
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
fcce390d-6460-4701-87cf-940d8800a1c3Product name220180212
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
bf065fa6-1e3b-e4c3-0bde-2dc842ceeea1Product name220150218
02657a3f-1489-66ea-f740-5ab9524e57d7Product name120140508
26f3d783-2cc1-4327-e77d-71804cf675a2Product name120140508
36fdc54c-bbeb-981e-8a53-4d768e283892Product name120140508
58f3f9b7-3b9b-a9c1-1c9f-18ac777192b8Product name120140508
61e59a42-186b-9f4b-aec3-fb49a6debc31Product name120140508
705740e1-dee5-2610-c5a3-4c59cd9d62afProduct name120140508
7bdc4804-3832-c0df-e519-72b6d47c9792Product name120140508
a7051cba-790b-a699-81f8-dbbbdbd9b5acProduct name120140508
abaf203f-619e-f265-559f-8c81af5cb1c2Product name120140508
acc4d8bb-0e29-e9f8-65f8-31e94184a9c0Product name120140508
b045ad64-0f28-9a02-2f9b-b34d94fb2278Product name120140508
bfd28ffb-d550-3fe9-f65b-10bcb7f971fdProduct name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
da108d9e-edc8-17a3-8c28-3251c6a8acccProduct name120140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508
fe21f3fd-a378-0654-1972-db3c3b64470eProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50383-901-102024-01-30C16284748780-11030e365-5e09-111a-e063-dadaa90a10e2Hydrocortisone and Acetic Acid Otic Solution, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50383-901-10hydrocortisone and acetic acid1 in 1 CARTONSOLUTION16
50383-901-10hydrocortisone and acetic acid10 mL in 1 BOTTLE, DROPPERSOLUTION106

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50383-901HYDROCORTISONE AND ACETIC ACID SOLUTION [AKORN OPERATING COMPANY LLC]6Legacy NDC, 2 package rows20221014_ffd1edc1-2f40-4b0a-a53a-9fb53b8d3184.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50383-901-10ML - Milliliter50383-901ee1e02fd-7a69-49a0-b204-8f4598d4bcdb12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ACETIC ACIDACTIVE INGREDIENTQ40Q9N063P3
HYDROCORTISONEACTIVE INGREDIENTWI4X0X7BPJ3
ACETIC ACIDACTIVE MOIETYQ40Q9N063P3
HYDROCORTISONEACTIVE MOIETYWI4X0X7BPJ3
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSL3
BENZETHONIUM CHLORIDEINACTIVE INGREDIENTPH41D057443
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V33
PROPYLENE GLYCOL DIACETATEINACTIVE INGREDIENT5Z492UNF9O3
SODIUM ACETATEINACTIVE INGREDIENT4550K0SC9B3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50383-90150383-901-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 183 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / TOPICAL1800 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3EMULSION / OPHTHALMIC1.5 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3EMULSION / TOPICAL8 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLPOWDER, FOR SOLUTION / ORAL123 mgExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS35 mgExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLTABLET / BUCCAL30 mgExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLFILM, SOLUBLE / ORAL7 mgExact identifier — unii candidate
61 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION, SOLUTION / INTRAVENOUS328 mgExact identifier — unii candidate
32 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / RESPIRATORY (INHALATION)5 mgExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLPOWDER, FOR SUSPENSION / ORAL570 mgExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM / BUCCAL1.48 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZETHONIUM CHLORIDEBENZETHONIUM CHLORIDEPH41D05744INJECTION / INTRAVENOUS1 mgExact identifier — unii candidate
6 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / TOPICAL5148 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUPPOSITORY / VAGINAL252 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3PASTE / DENTAL0.5 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLLOZENGE / TRANSMUCOSAL44 mgExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / OPHTHALMIC0.44 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / RECTAL27 mgExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLINJECTION / INFILTRATION0.02 %w/vExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CLOTH / TOPICAL0.03 mg/mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / VAGINAL6.4 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLGEL / TOPICAL3 mgExact identifier — unii candidate
61 equally ranked IID candidates
BENZETHONIUM CHLORIDEBENZETHONIUM CHLORIDEPH41D05744CREAM / TOPICALNAExact identifier — unii candidate
6 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / AURICULAR (OTIC)56.55 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLOIL / TOPICAL2 mgExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLAEROSOL, FOAM / TOPICAL6 mgExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / DENTAL2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BLIQUID / INTRAVENOUS0.2 %w/vExact identifier — unii candidate
32 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BCREAM / TOPICALNAExact identifier — unii candidate
32 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION / SUBCUTANEOUS19 mgExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / ORAL2590 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BSOLUTION / ORAL44 mgExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SHAMPOO, SUSPENSION / TOPICAL2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3DROPS / ORAL200 mg/1mlExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION, EXTENDED RELEASE / ORAL1000 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE / ORAL1072 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM, SOLUBLE / BUCCAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION/ DROPS / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY / NASAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT, AUGMENTED / TOPICAL714 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAMUSCULAR7459 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION / INTRAMUSCULAR19 mgExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED, EXTENDED RELEASE / ORAL19 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYRUP / ORAL5700 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM ACETATESODIUM ACETATE4550K0SC9BINJECTION / INTRAVENOUS4239 mgExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM, EXTENDED RELEASE / TRANSDERMAL58.13 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LOTION, AUGMENTED / TOPICAL2070 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSUSPENSION / ORAL400 mgExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLLIQUID / INTRAVENOUS18 mgExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / VAGINAL750 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SWAB / TOPICAL34.6 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, EXTENDED RELEASE / ORAL9 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / RECTAL90400 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOL DIACETATEPROPYLENE GLYCOL DIACETATE5Z492UNF9OCREAM / TOPICAL10 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION/ DROPS / OPHTHALMIC0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS63.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
BENZETHONIUM CHLORIDEBENZETHONIUM CHLORIDEPH41D05744SOLUTION / AURICULAR (OTIC)0.02 %w/vExact identifier — unii candidate
6 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / ORAL3900 mgExact identifier — unii candidate
61 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N012770-001VOSOL HCACETIC ACID, GLACIAL; HYDROCORTISONE2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N012770-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N012770-001VOSOL HC2%;1%SOLUTION/DROPS / OTICATRLD, RS, Approved before 1982f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08N012770-001AT184e616aacf4f…
2026-08-18 06:07:402026-07N012770-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N012770-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N012770-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08N012770-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N012770-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N012770-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N012770-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N012770-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N012770-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N012770-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N012770-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N012770-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N012770-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N012770-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N012770-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N012770-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N012770-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N012770-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N012770-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N012770-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N012770-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N012770-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03N012770-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N012770-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N012770-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N012770-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09N012770-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07N012770-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N012770-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N012770-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N012770-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N012770-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N012770-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N012770-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N012770-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05N012770-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01N012770-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N012770-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N012770-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9b68befb-ac5a-4db8-a8cf-24a89bbf3155ffd1edc1-2f40-4b0a-a53a-9fb53b8d31842022-10-13Warnings, Adverse reactionsExact identifier
spl id: 9b68befb-ac5a-4db8-a8cf-24a89bbf3155
spl set id: ffd1edc1-2f40-4b0a-a53a-9fb53b8d3184

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.